| Marlene R. Krauss |
In August 1991, Dr. Krauss co-founded KBL Healthcare, Inc. and has served as its chairperson and chief executive officer since its formation. In June 1999, she co-founded Lumenos and has served as a member of its board of directors since its formation. From April 1993 to August 1994, she served as chairperson and chief executive officer of KBL I. Following its merger with Concord, she served as the vice chairperson until February 1996.
Dr. Krauss is also a member of the board of directors of PneumRx, Inc., a medical device company developing products for interventional pulmonology applications, of Prolong Pharmaceuticals, a drug delivery company, and of CardioFocus, Inc., an interventional cardio vascular company treating atrial fibrillation.
Dr. Krauss received a B.A. from Cornell University, an M.B.A. from Harvard Graduate School of Business Administration and an M.D. from Harvard Medical School. She trained at the Harvard affiliated hospitals, the Beth Israel Hospital and the Deaconess Hospital, as well as Mt. Sinai Hospital in New York. She completed her training as a vitreoretinal surgeon at New York Hospital in 1985 and was Clinical Instructor of Ophthalmology at New York Hospital and is a Board Certified Ophthalmologist. She is the wife of Dr. Berk. |
| Joseph A. Williamson |
Founder of Brandywine Senior Care, Inc., Concord Health Group, Inc. and Healthcare Resources Corp., Joseph A. Williamson is an entrepreneur and businessperson who has been at the head of 9 different companies and holds the position of Chief Operating Officer & Director at KBL Merger Corp. IV. Mr. Williamson is also on the board of KBL Acquisition Corp. IV and PA Options for Wellness, Inc. and Advisory Board Member at KBL Healthcare Ventures, Managing Partner at Jaw Capital LLC and Partner at Vantage Point LP.
Joseph A. Williamson previously occupied the position of Chairman & Chief Executive Officer for Brandywine Senior Care, Inc., Chairman & Chief Executive Officer of Brandywine Senior Living LLC, Chairman & Chief Executive Officer at National Medical & Security Holdings LLC, Chairman for National Hospice Holdings Investors LLC, Limited Partner at NSV II Management Co. LLC and General Partner at Commerce Health Ventures LP (a subsidiary of NSV II Management Co. LLC), Chairman at Millenium Home Health Care, Inc., Chairman at National Hospice Holdings LLC, President & Chief Executive Officer of Healthcare Resources Corp., President & Chief Operating Officer for Concord Health Group, Inc., President & Chief Executive Officer at NeighborCare, Inc. and Principal at NeighborCare, Inc.
He received an undergraduate degree from Villanova University, a graduate degree from Widener University and an MBA from Temple University (Pennsylvania). |
| George Ronald Hornig |
Founder of Cleantech Group LLC and Wasserstein Perella & Co., Inc., George Ronald Hornig is a businessperson who has been the head of 9 different companies and presently is Chairman at KBL Merger Corp. IV and Chief Operating Officer for 180 Life Sciences Corp. Mr. Hornig is also on the board of Edelman & Co Ltd, Xometry, Inc. and Syntax Advisors LLC.
In the past he held the position of Chief Executive Officer of Ron Transatlantic Financial Holdings LLC, President & Chief Executive Officer for Credit Suisse High Yield Bond Fund, President & Chief Executive Officer of Credit Suisse Asset Management Income Fund, Inc., Chief Operating Officer for Wasserstein Perella & Co., Inc., President & Chief Executive Officer for The Emerging Markets Telecommunications Fund, Inc., President & Chief Executive Officer for The Indonesia Fund, Inc., Chief Executive Officer for The Latin America Equity Fund, Inc., President & Chief Executive Officer of The First Israel Fund, Inc., President & Chief Executive Officer for The Chile Fund, Inc., Chief Operating Officer at PineBridge Investments LLC, Executive Vice President & COO-Americas at Deutsche Bank Corp., Chief Operating Officer-Alternative Investments at Credit Suisse AG and Director at Cleantech Group LLC.
He received an MBA and a graduate degree from Harvard Business School. |
| Paul Sherrill Neff |
Mr. Paul S. Neff is an Independent Director at KBL Merger Corp. IV, an Independent Director at Exantas Capital Corp. and a Founding Partner at Quaker Partners Management LP. He is on the Board of Directors at KBL Merger Corp. IV, Rapid Micro Biosystems, Inc., Vesper Medical, Inc., Intact Vascular, Inc., RainDance Technologies, Inc., Exantas Capital Corp. and Greater Philadelphia Venture Group.
Mr. Neff was previously employed as an Independent Director by Cempra Pharmaceuticals, Inc., an Independent Director by Cempra, Inc., an Independent Director by Regado Biosciences, Inc., a Senior Vice President-Corporate Development by US Healthcare, Inc., a Managing Director by Alex. Brown & Sons, Inc., an Attorney by Morgan, Lewis & Bockius LLP, a President by Life Sciences Pennsylvania, and a Partner by Quaker Partners LLC. He also served on the board at National Venture Capital Association, Neuronetics, Inc., Biolex Therapeutics, Inc., The Bancorp, Inc. (Delaware), Resource America LLC, Amicus Therapeutics, Inc., Neose Technologies, Inc., BioRexis Pharmaceutical Corp., Cellgate, Inc., Durata Therapeutics, Inc., Jefferson Bank (Dallas, Texas), Medmark, Inc., Optherion, Inc., The Biotechnology Institute and University City Science Center.
He received his undergraduate degree from Wesleyan University and a graduate degree from The University of Michigan Law School. |
| Andy Sherman |
Mr. Andy Sherman is a Managing Director at Morgan Joseph TriArtisan LLC. Prior to joining Morgan Joseph TriArtisan in 2011, he was a senior member of the Healthcare Investment Banking Group at Madison Williams. From 2007 to 2009, he worked in principal investing for KBL Healthcare Acquisition Corp. and Capitol Acquisition Corp., sourcing and executing transactions across various industries including healthcare services, specialty pharmaceuticals, and medical devices. From 2001 to 2007, he was at Banc of America Securities where he was a Principal in Investment Banking. Earlier, he worked at Montgomery Securities and James D. Wolfensohn, Inc.
Mr. Sherman received a Masters of Business Administration with Distinction from Harvard Business School, a B.S. in Economics from the Wharton School of Business and a B.A. in International Relations from the University of Pennsylvania. |
